RBC Capital analyst Gregory Renza maintained a Buy rating on Nuvation Bio (NUVB – Research Report) today and set a price target of $6.00.

RBC Capital analyst Gregory Renza maintained a Buy rating on Verastem (VSTM – Research Report) today and set a price target of $13.00.

Gerard Cassidy, RBC Capital Markets large cap bank analyst, joins 'Squawk Box' to discuss Donald Trump's victory in the 2024 ...

Fintel reports that on November 5, 2024, RBC Capital downgraded their outlook for Verrica Pharmaceuticals (NasdaqGM:VRCA) ...

Former RBC advisor claims firm discriminated against her, and the timing of her firing could let the firm take a large portion of her book without compensation.

A big part of the trouble with the RBC rule is that Ginnie Mae is essentially using its limited legal authority to qualify ...

Fidelity National Information Services beats Q3 estimates, and raises full-year outlook Analysts maintain rating.

CNW/ - RBC has launched a new approach to community investment aimed at helping to address some of society's most pressing challenges. RBC, RBC Foundation ...

Nissan, Mitsubishi to form JV for robotaxi, EV battery services. Stonepeak near deal to acquire Air Transport Services Group in $3.1B deal. Palantir Q3 Earnings Preview.

Earnings season is upon us, and the Canadian banks will be reporting before you know it. So which of these two are on top?

Investing.com -- Shares of Burberry (LON: BRBY) saw a rise on Wednesday following an upgrade by RBC Capital Markets to an "outperform" rating from a "sector perform” rating, accompanied by a price ...

Forbes Advisor ranks the best business bank accounts in Canada to determine which best serves businesses, large or small.